Tocqueville Asset Management L.P. Tempest Therapeutics, Inc. Transaction History

Tocqueville Asset Management L.P.

  • $6.27 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024
SELL
$0.96 - $2.23 $7,680 - $17,840
-8,000 Reduced 19.63%
32,750 $45,000
Q2 2024

Aug 12, 2024
BUY
$2.01 - $5.44 $53,767 - $145,520
26,750 Added 191.07%
40,750 $89,000
Q4 2023

Feb 12, 2024
BUY
$0.23 - $9.77 $3,220 - $136,780
14,000 New
14,000 $61,000

Others Institutions Holding TPST

# of Institutions
38
Shares Held
5.53M
Call Options Held
44.9K
Put Options Held
109K
View Full List

About Tempest Therapeutics, Inc.

TPST Quotes by TradingView
  • Ticker TPST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 10,418,900
  • Market Cap $9.69M
  • Description
  • Tempest Therapeutics Inc., a clinical-stage oncology company, engages in developing small molecule therapeutics to treat cancer. The company's two clinical programs are TPST-1495, a dual antagonist of EP2 and EP4, receptors of prostaglandin E2, and is currently in a Phase 1 trial in solid tumors; and TPST-1120, a selective antagonist of peroxiso...
More about TPST
Track This Portfolio

Track Tocqueville Asset Management L.P. Portfolio

Follow Tocqueville Asset Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tocqueville Asset Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Tocqueville Asset Management L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email